Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 3.2.2023Angelini Pharma Österreich GmbH (ANG-AT-1)0418ATANTUM VERDE Orange & Honey (pas ord 20x3 mg (obal papier))25.1.2023R
 3.2.2023Angelini Pharma Česká republika s.r.o. (AIP-2)87073ERDOMED 225 mg (gru por 20x225 mg (vrecko papier/Al/PE))2.2.2023O
 3.2.2023Angelini Pharma Österreich GmbH (ANG-AT-1)94683TANTUM VERDE SPRAY FORTE (aer ora 1x15 ml (liek.HDPE))2.2.2023O
 3.2.2023Zentiva, k.s. (ZNT-1)01076Ophthalmo-Framykoin (ung oph 1x5 g (tuba Al))8.2.2023O
 3.2.2023Zentiva, k.s. (ZNT-1)01077OPHTHALMO-FRAMYKOIN comp. (ung oph 1x5 g (tuba Al))8.2.2023O
 3.2.2023Zentiva, k.s. (ZNT-1)1797DGUAJACURAN (tbl obd 50x200 mg (blis.Al/PVC))7.2.2023O
 3.2.2023Zentiva, k.s. (ZNT-1)34740Rispen 1 (tbl flm 20x1 mg (blis.PVC/PVDC/Al))3.2.2023O
 3.2.2023Zentiva, k.s. (ZNT-1)34742Rispen 1 (tbl flm 50x1 mg (blis.PVC/PVDC/Al))3.2.2023O
 3.2.2023Zentiva, k.s. (ZNT-1)81775Valzap 160 mg (tbl flm 28x160 mg (blis.PVC/PE/PVDC/Al))3.2.2023O
 3.2.2023GlaxoSmithKline Trading Services Limited (GAG-IRL-3)12494Augmentin 1 g (tbl flm 14x1 g (blis.Al/PVC/PVDC))26.1.2023R
 3.2.2023GlaxoSmithKline Trading Services Limited (GAG-IRL-3)93709Augmentin 375 mg (tbl flm 21x375 mg (blis.PVC/PVDC/Al))26.1.2023R
 3.2.2023MEDOCHEMIE Ltd. (MOE)2791CVERRIA 200 mg filmom obalené tablety (tbl flm 14x200 mg (blis.PVC/Al))1.2.2023R
 3.2.2023MEDOCHEMIE Ltd. (MOE)37099ARKETIS 20 mg (tbl 30x20 mg (blis.PVC/Al))1.2.2023R
 3.2.2023MEDOCHEMIE Ltd. (MOE)37101ARKETIS 20 mg (tbl 60x20 mg (blis.PVC/Al))1.2.2023R
 3.2.2023MEDOCHEMIE Ltd. (MOE)37109ARKETIS 30 mg (tbl 30x30 mg (blis.PVC/Al))1.2.2023R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)